HPN and breast cancer: Poorly differentiated tumors expressed lower levels of both TMPRSS1 and TMPRSS3. Notably, both mRNA and protein expression levels were associated with the clinical characteristics of breast cancer: Low expression levels predicted poorer survival and increased risk of distant metastasis compared to high expression levels.